Working… Menu

A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00323518
Recruitment Status : Completed
First Posted : May 9, 2006
Last Update Posted : April 13, 2016
Information provided by (Responsible Party):
Celldex Therapeutics ( CuraGen Corporation )

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 2008
Actual Study Completion Date : August 2008
Certification/Extension First Submitted : February 2, 2015